SBC Medical Group Holdings Inc. (NASDAQ: SBC), a Japanese operator of aesthetic medical clinics and provider of consulting services, is making its first major move into the U.S. market through a strategic investment in OrangeTwist, a U.S.-based medspa chain. The partnership, announced late last month, positions SBC to leverage OrangeTwist's 24 locations across six states and its expertise in non-invasive treatments such as injectables, energy-based procedures, and regenerative therapies.
The medical aesthetics industry is projected to grow from $34 billion today to $48 billion by 2030, driven by demand for low-risk, minimal-downtime procedures. The aging U.S. population further fuels this trend, with 4.1 million people turning 65 each year through 2027. SBC aims to address market gaps, or "white space," by opening new clinics in underserved high-demand areas, gaining a first-mover advantage.
Stephen Rodgers, global head of planning and strategy at SBC Medical, emphasized the company's focus on local partnerships. "As part of SBC’s global expansion, we are working hard to find local partnerships rather than copying and pasting what we did in Japan," he told Benzinga. SBC seeks partners aligned with its mission, in leadership positions, and capable of scaling. Beyond joint operations, OrangeTwist and SBC plan to co-develop branded products and cross-sell existing offerings.
The longevity industry, valued at approximately $85 billion in 2025 and expected to surpass $120 billion by 2030 according to Gabelli Research, presents additional opportunities. North America accounts for about 30% of this market, with Asia also showing robust growth. SBC is well-positioned to offer services such as AI-powered diagnostics, GLP-1 weight-loss drugs, and regenerative therapies, leveraging its infrastructure and track record in high-quality, cost-efficient care.
Beyond the U.S., SBC is expanding in Japan and Southeast Asia, applying its proven business model to help clinics with management, staff training, and equipment procurement. The company's global strategy rests on partnering with high-performing regional operators, deploying operational efficiencies, and securing first-mover advantages. Standardizing services ensures consistent quality and pricing across markets, appealing to consumers who prefer natural-looking results with minimal recovery time.
SBC Medical's network of 258 affiliated clinics manages over six million patient visits annually. The partnership with OrangeTwist also involves institutional shareholders Hildred Capital and Athyrium Capital. To learn more about SBC Medical, click here.
This content was originally published on Benzinga. Read further disclosures here.
